Amgen (AMGN) Free Cash Flow (2009 - 2026)

Amgen has reported Free Cash Flow for 18 years, with the latest figure at $3.5 billion in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 82.57% year-over-year to $3.5 billion in Q2 2026; TTM through Jun 2026 was $10.2 billion, a 4.05% decrease from a year earlier, with the FY2025 full-year figure at $8.1 billion, down 22.07% from the prior year.
• Free Cash Flow was $3.5 billion for Q2 2026 at Amgen, up from $1.5 billion in the prior quarter.
• The five-year high for Free Cash Flow was $4.4 billion in Q4 2024, with the low at $289.0 million in Q4 2023.
• Average Free Cash Flow over 5 years is $2.2 billion, with a median of $2.1 billion recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow slumped 87.48% in 2023, then surged 1422.49% in 2024.
• Over 5 years, Free Cash Flow stood at $2.3 billion in 2022, then plunged by 87.48% to $289.0 million in 2023, then soared by 1422.49% to $4.4 billion in 2024, then sank by 78.16% to $961.0 million in 2025, then surged by 263.06% to $3.5 billion in 2026.
• The last three Free Cash Flow figures came in at $3.5 billion (Q2 2026), $1.5 billion (Q1 2026), and $961.0 million (Q4 2025), per Business Quant data.